BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 25 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $975 | -3.2% | 2,998 | +6.6% | 0.00% | – |
| Q4 2022 | $1,007 | -49.6% | 2,812 | -3.4% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 2,912 | +219.3% | 0.00% | – |
| Q2 2022 | $1,000 | -87.5% | 912 | -5.2% | 0.00% | – |
| Q1 2022 | $8,000 | +700.0% | 962 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -66.7% | 962 | -13.6% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 1,113 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 1,113 | -10.5% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 1,244 | +38.8% | 0.00% | – |
| Q4 2020 | $3,000 | -57.1% | 896 | -7.7% | 0.00% | – |
| Q3 2020 | $7,000 | -12.5% | 971 | -3.0% | 0.00% | – |
| Q2 2020 | $8,000 | +166.7% | 1,001 | +4.8% | 0.00% | – |
| Q1 2020 | $3,000 | – | 955 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 448,101 | $537,000 | 0.11% |
| Long Focus Capital Management, LLC | 327,692 | $393,000 | 0.04% |
| Boxer Capital, LLC | 56,950 | $68,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $16,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $299,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 45,057 | $54,000 | 0.00% |
| Orion Capital Management LLC | 500 | $1,000 | 0.00% |
| Parallel Advisors, LLC | 10 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 779 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 10,981 | $13,000 | 0.00% |